文献速递妇产影像外周血管US

妊娠19-24周子痫前期联合筛查后的拟议临床管理方案

Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
PubMed 文献 · Ultrasound Obstet Gynecol · 2017-07-31

这项前瞻性观察研究纳入7748例单胎妊娠,在19-24周用孕妇特征与病史联合MAP、UtA-PI、PlGF和sFlt-1的MoM值计算子痫前期风险并分层。采用<32周子痫前期风险1/100、<36周风险1/300的界值,高危组占0.9%并包含97%的<32周子痫前期,中危组占17.2%,低危组占81.9%。

要点

  • 19-24周联合筛查可将孕妇分为高、中、低危三组,高危组占0.9%但含97%的<32周子痫前期。
  • 中危组占17.2%,含46%的32-35周子痫前期,低危组仅含9%的32-35周子痫前期。
  • 风险界值取<32周子痫前期1/100、<36周子痫前期1/300时得到上述分层比例。

核心结论

  • 19-24周联合筛查风险分层可识别占总人群<1%但含>95%的<32周子痫前期高危组,以及占总人群<20%但含>90%的32-35周子痫前期中危组。

研究设计与样本

  • 前瞻性观察研究,纳入7748例在19-24周接受常规孕期超声检查的单胎妊娠,采用竞争风险模型结合孕妇特征与病史及MAP、UtA-PI、PlGF、sFlt-1的MoM值计算风险。

诊断标准与关键数值

  • 以<32周子痫前期风险1/100和<36周子痫前期风险1/300为界值,高危组占0.9%、中危组占17.2%、低危组占81.9%,分别含97%、46%和0.03%的<32周子痫前期及45%、46%和9%的32-35周子痫前期。

临床应用与阅片要点

  • 高危组需在24-31周接受密集监测,中危组需在32周重新评估,低危组占81.9%且仅含9%的32-35周子痫前期。

局限性

  • 原文指出<32周分娩的子痫前期病例数少,因此除经验性能外还推导了基于模型的性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To estimate the patient-specific risk of pre-eclampsia (PE) at 19-24 weeks' gestation by a combination of maternal characteristics and medical history with multiples of the median (MoM) values of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum placental growth factor (PlGF) and serum soluble fms-like tyrosine kinase-1 (sFlt-1), and stratify women into high-, intermediate- and low-risk management groups.

METHODS: This was a prospective observational study in women attending a second-trimester ultrasound scan at 19-24 weeks as part of routine pregnancy care. Patient-specific risks of delivery with PE < 32 weeks and < 36 weeks' gestation were calculated using the competing-risks model to combine the prior risk from maternal characteristics and medical history with MoM values of MAP, UtA-PI, PlGF and sFlt-1. On the basis of these risks, the population was stratified into high-, intermediate- and low-risk groups. Different risk cut-offs were used to vary the proportion of the population stratified into each risk category and the performance of screening for delivery with PE at < 32 weeks' gestation, at 32-35 weeks and at ≥ 36 weeks was estimated. In addition to empirical performance, we also derived model-based performance because the number of cases of PE delivering < 32 weeks was low.

RESULTS: The study population of 7748 singleton pregnancies included 268 (3.5%) that subsequently developed PE. Using a risk cut-off of 1 in 100 for PE delivering < 32 weeks' gestation and a risk cut-off of 1 in 300 for PE delivering < 36 weeks, the proportion of the population stratified into high-, intermediate- and low-risk was 0.9%, 17.2% and 81.9%, respectively. The high-risk group contained 97% of pregnancies with PE < 32 weeks and 45% of those with PE at 32-35 weeks. The intermediate-risk group contained a further 46% of women with PE at 32-35 weeks. The low-risk group contained only 0.03% of pregnancies with PE < 32 weeks and 9% of those with PE at 32-35 weeks.

CONCLUSION: Risk stratification of PE by the combined test at 19-24 weeks' gestation can identify, first, a group which constitutes < 1% of the total population and contains > 95% of those that will develop PE < 32 weeks and are in need of intensive monitoring at 24-31 weeks and, second, a group which constitutes < 20% of the total and contains > 90% of those that will develop PE at 32-35 weeks and are in need of reassessment at 32 weeks. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Litwinska M, Wright D, Efeturk T, et al. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol. 2017. PMID: 28133831. doi:10.1002/uog.17418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。